The S region of the murine histocompatibility complex (H-2) was defined almost 25 years ago as a genetic locus controlling the quantity of Ss (serum substance) in mouse serum. Subsequent work from a number of laboratories established that Ss is composed of two distinct proteins: C4, the murine fourth component of complement, and sex-limited protein (Slp), a protein that shares extensive structural and biochemical identity with C4 but which lacks C4 activity. Slp is notable in that its expression is testosterone-dependent and hence limited to males in some strains while in other strains expression is either independent of testosterone or conversely completely undetectable. Recent nucleic acid cloning and sequencing studies in our laboratory and others have demonstrated that C4 and Slp are encoded by distinct structural genes that lie in the S region and are doubtless the products of gene duplication. The goals of the proposed program are (a) to determine and compare the structural organization of the C4 and Slp genes; (b) to understand the structural and evolutionary relationships between these genes and other genes, in particular the class I and class II genes of the H-2 complex and the genes for the related complement proteins C3 and C5; and (c) to characterize the molecular mechanisms controlling sex-, tissue-, and strain- specific expression of the C4 and Slp genes. We propose to use recombinant DNA cloning and sequencing methods (a) to sequence the entire transcribed regions of the C4 and Slp genes; (b) to extend our study of upstream regions of the C4 and Slp genes by mapping restriction enzyme cleavage sites and by DNA sequencing; (c) to sequence regions upstream of the transcription initiation sites of C4 and Slp genes from mouse strains that exhibit varied C4 and Slp expression phenotypes; and (d) to use site-specific mutation and DNA reconstruction methods, together with methods for expression in cell culture to identify the gene segments responsible for regulating C4 and Slp expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM029831-07
Application #
3277506
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1981-04-01
Project End
1992-11-30
Budget Start
1987-12-01
Budget End
1988-11-30
Support Year
7
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Medical Biology Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Clark, Carla; Thai, Chuong-Thu; Phelan, Marie M et al. (2013) ¹H, ¹³C and ¹?N resonance assignments of the complement control protein modules of the complement component C7. Biomol NMR Assign 7:285-8
Phelan, Marie M; Thai, Chuong-Thu; Herbert, Andrew P et al. (2009) 1H, 15N and 13C resonance assignment of the pair of Factor-I like modules of the complement protein C7. Biomol NMR Assign 3:49-52
Bramham, Janice; Thai, Chuong-Thu; Soares, Dinesh C et al. (2005) Functional insights from the structure of the multifunctional C345C domain of C5 of complement. J Biol Chem 280:10636-45
Thai, Chuong-Thu; Ogata, Ronald T (2005) Recombinant C345C and factor I modules of complement components C5 and C7 inhibit C7 incorporation into the complement membrane attack complex. J Immunol 174:6227-32
Thai, Chuong-Thu; Ogata, Ronald T (2004) Complement components C5 and C7: recombinant factor I modules of C7 bind to the C345C domain of C5. J Immunol 173:4547-52
Bramham, Janice; Rance, Mark; Thai, Chuong-Thu et al. (2004) 1H, 15N and 13C resonance assignments of the C345C domain of the complement component C5. J Biomol NMR 29:217-8
Thai, Chuong-Thu; Ogata, Ronald T (2003) Expression and characterization of the C345C/NTR domains of complement components C3 and C5. J Immunol 171:6565-73
Sandoval, A; Ai, R; Ostresh, J M et al. (2000) Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5. J Immunol 165:1066-73
Low, P J; Ai, R; Ogata, R T (1999) Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family. J Immunol 162:6580-8
Ogata, R T; Ai, R; Low, P J (1998) Active sites in complement component C3 mapped by mutations at indels. J Immunol 161:4785-94

Showing the most recent 10 out of 28 publications